Published in AIDS Weekly, April 10th, 2000
These data were presented at the "International Workshop on Immunotherapy in HIV Infection" held in Israel during March 2000. This potential new preventive HIV vaccine appears to boost key elements of the immune response in animals, including both T-helper and T-killer cell activity that may be involved in protection against HIV infection.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.